MACROGENICS INC's ticker is MGNX and the CUSIP is 556099109. A total of 134 filers reported holding MACROGENICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $459,184 | -75.2% | 85,829 | -66.7% | 0.00% | -75.0% |
Q1 2023 | $1,849,487 | +124.5% | 257,948 | +8.2% | 0.00% | +100.0% |
Q3 2022 | $824,000 | -59.8% | 238,299 | -65.7% | 0.00% | -50.0% |
Q2 2022 | $2,050,000 | +388.1% | 694,944 | +3365.9% | 0.00% | +100.0% |
Q3 2021 | $420,000 | -51.8% | 20,051 | -47.4% | 0.00% | -60.0% |
Q4 2020 | $871,000 | +136.0% | 38,123 | -39.9% | 0.01% | +25.0% |
Q1 2020 | $369,000 | +130.6% | 63,476 | +610.0% | 0.00% | +300.0% |
Q1 2019 | $160,000 | -82.8% | 8,940 | -79.4% | 0.00% | -75.0% |
Q3 2018 | $928,000 | -75.0% | 43,326 | -76.1% | 0.00% | -83.3% |
Q4 2016 | $3,705,000 | +29.4% | 181,267 | +89.4% | 0.02% | +20.0% |
Q3 2016 | $2,863,000 | -13.3% | 95,716 | -21.8% | 0.02% | -28.6% |
Q2 2016 | $3,304,000 | +70.3% | 122,430 | +18.3% | 0.03% | +47.4% |
Q1 2016 | $1,940,000 | -33.1% | 103,458 | +10.4% | 0.02% | -29.6% |
Q4 2015 | $2,902,000 | +180.7% | 93,709 | +94.1% | 0.03% | +107.7% |
Q3 2015 | $1,034,000 | +271.9% | 48,287 | +382.9% | 0.01% | +160.0% |
Q1 2014 | $278,000 | – | 10,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 1,215,675 | $6,503,861 | 2.01% |
Bellevue Group AG | 9,609,913 | $51,413,035 | 0.73% |
Frazier Life Sciences Management, L.P. | 1,803,204 | $9,647,141 | 0.58% |
ARMISTICE CAPITAL, LLC | 5,600,000 | $29,960,000 | 0.43% |
Delphia (USA) Inc. | 37,988 | $203,236 | 0.32% |
SECTORAL ASSET MANAGEMENT INC | 352,497 | $1,885,859 | 0.31% |
Corton Capital Inc. | 73,678 | $394,177 | 0.18% |
Rock Springs Capital Management LP | 1,123,096 | $6,008,564 | 0.14% |
GSA CAPITAL PARTNERS LLP | 129,158 | $691 | 0.07% |
PINNACLE ASSOCIATES LTD | 709,903 | $3,797,981 | 0.07% |